Testing for isotypes does not help differentiating rheumatoid arthritis from other rheumatoid factor positive diseases.


Journal

Immunologic research
ISSN: 1559-0755
Titre abrégé: Immunol Res
Pays: United States
ID NLM: 8611087

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 11 04 2023
accepted: 01 06 2023
medline: 24 11 2023
pubmed: 16 6 2023
entrez: 15 6 2023
Statut: ppublish

Résumé

Rheumatoid factors (RFs) are useful for diagnosis and classification of rheumatoid arthritis (RA). Nephelometric and turbidimetric techniques, which detect total RF but do not reveal the antibody isotype, are common diagnostic methods in clinical routine. Given the recent development of isotype-specific immunoassays, the detection of IgG, IgM, and IgA RFs represents an interesting challenge. The aim of the study was to evaluate whether specific RF tests performed as a second step after traditional nephelometry could help differentiating RA from other RF-positive diseases. We tested 117 consecutive serum samples that were RF-positive at nephelometry (BNII nephelometric analyzer, Siemens) for IgA, IgG, and IgM RF isotypes by a fluoroimmunoenzymatic assay (FEIA) on the Phadia 250 instrument (ThermoFisher). Fifty-five subjects had RA and 62 presented non-RA diagnoses. Eighteen sera (15.4%) were positive only by nephelometry, two were positive only for IgA RF, and the remaining 97 sera were all positive for IgM RF isotype (with or without IgG and IgA RF). Positive findings did not correlate with RA or non-RA diagnosis. Spearman rho correlation coefficient between nephelometric total RF and IgM isotype was moderate (0.657), and weak between total RF and IgA (0.396) and IgG (0.360) isotypes. Despite its low specificity, measurement of total RF by nephelometry still seems to be the method that performs best. As IgM, IgA, and IgG RF isotypes showed only a moderate correlation with total RF measurement, their diagnostic use as a second level test remains controversial.

Identifiants

pubmed: 37322352
doi: 10.1007/s12026-023-09402-3
pii: 10.1007/s12026-023-09402-3
doi:

Substances chimiques

Rheumatoid Factor 9009-79-4
Immunoglobulin G 0
Immunoglobulin A 0
Immunoglobulin M 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

883-886

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Shiroishi M, Ito Y, Shimokawa K, et al. Structure-function analyses of a stereotypic rheumatoid factor unravel the structural basis for germline-encoded antibody autoreactivity. J Biol Chem. 2018;293:7008–16.
doi: 10.1074/jbc.M117.814475 pubmed: 29523691 pmcid: 5936827
Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. 1939. APMIS. 2007;115:422–38. discussion 439
doi: 10.1111/j.1600-0463.2007.apm_682a.x pubmed: 17504400
Rose HM, Ragan C, Pearce E, et al. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med. 1948;68:1–6.
doi: 10.3181/00379727-68-16375 pubmed: 18863659
Pike RM, Sulkin SE, Coggeshall HC. Serological reactions in rheumatoid arthritis; factors affecting the agglutination of sensitized sheep erythrocytes in rheumatoid-arthritis serum. J Immunol. 1949;63:441–6.
doi: 10.4049/jimmunol.63.4.441 pubmed: 15398122
Renaudineau Y, Jamin C, Saraux A, et al. Rheumatoid factor on a daily basis. Autoimmunity. 2005;38:11–6.
doi: 10.1080/08916930400022574 pubmed: 15804700
Roberts-Thomson PJ, Wernick RM, Ziff M. Quantitation of rheumatoid factor by laser nephelometry. Rheumatol Int. 1982;2:17–20.
doi: 10.1007/BF00541265 pubmed: 7178761
Nykänen M, Palosuo T, Aho K, et al. Improved immunoturbidimetric method for rheumatoid factor testing. J Clin Pathol. 1993;46:1065–6.
doi: 10.1136/jcp.46.11.1065 pubmed: 8254101 pmcid: 501701
Tuomi T. Which antigen to use in the detection of rheumatoid factors? Comparison of patients with rheumatoid arthritis and subjects with ‘false positive’ rheumatoid factor reactions. Clin Exp Immunol. 1989;77:349–55.
pubmed: 2805406 pmcid: 1542059
Bonagura VR, Artandi SE, Davidson A, et al. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors. J Immunol. 1993;151:3840–52.
doi: 10.4049/jimmunol.151.7.3840 pubmed: 7690818
Anderson SG, Bentzon MW, Houba V, et al. International reference preparation of rheumatoid arthritis serum. Bull World Health Organ. 1970;42:311–8.
pubmed: 5310143 pmcid: 2427447
Ameratunga R, Musaad S, Sugrue C, et al. Rheumatoid factor measurement—continuing problems 70 years after discovery. Clin Rheumatol. 2011;30:1215–20.
doi: 10.1007/s10067-011-1716-3 pubmed: 21455659
Rippey JH, Biesecker JL. Results of tests for rheumatoid factor on CAP survey specimens. Am J Clin Pathol. 1983;80(4 Suppl):599–602.
pubmed: 6624729
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
doi: 10.1002/art.1780310302 pubmed: 3358796
Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8.
doi: 10.1136/ard.2010.138461 pubmed: 20699241
Haberman AM, William J, Euler C, et al. Rheumatoid factors in health and disease: structure, function, induction and regulation. Curr Dir Autoimmun. 2003;6:169–95.
doi: 10.1159/000066861 pubmed: 12408052
Motta F, Bizzaro N, Giavarina D, et al. Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis - a systematic review and meta-analysis. RMD Open. 2023; (in press)
van Hoovels L, Studenic P, Sieghart D, et al. Impact of autoimmune serology test results on RA classification and diagnosis. J Transl Autoimmun. 2022;5
van Hoovels L, Jacobs J, vander Cruyssen B, et al. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis. Ann Rheum Dis. 2018;77:667–77.
doi: 10.1136/annrheumdis-2017-212365 pubmed: 29363510
Rönnelid J, Turesson C, Kastbom A. Autoantibodies in rheumatoid arthritis - laboratory and clinical perspectives. Front Immunol. 2021;12
Falkenburg WJJ, von Richthofen HJ, Koers J, et al. Clinically relevant discrepancies between different rheumatoid factor assays. Clin Chem Lab Med. 2018;56:1749–58.
doi: 10.1515/cclm-2017-0988 pubmed: 29427550
Stone R, Coppock JS, Dawes PT, et al. Clinical value of ELISA assays for IgM and IgG rheumatoid factors. J Clin Pathol. 1987;40:107–11.
doi: 10.1136/jcp.40.1.107 pubmed: 3818968 pmcid: 1140839
van der Linden MP, Batstra MR, Bakker-Jonges LE, et al. Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor? Arthritis Rheum. 2011;63:1190–9.
doi: 10.1002/art.30200 pubmed: 21538311
Bas S, Perneger TV, Kunzle E, et al. Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors. Ann Rheum Dis. 2002;61:505–10.
doi: 10.1136/ard.61.6.505 pubmed: 12006322 pmcid: 1754117
Sieghart D, Platzer A, Studenic P, et al. Determination of autoantibody isotypes increases the sensitivity of serodiagnostics in rheumatoid arthritis. Front Immunol. 2018;24:876.
doi: 10.3389/fimmu.2018.00876
Infantino M, Manfredi M, Meacci F, et al. Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests. Clin Chim Acta. 2014;436:237–42.
doi: 10.1016/j.cca.2014.05.019 pubmed: 24892812
van Hoovels L, vander Cruyssen B, Sieghart D, et al. IgA rheumatoid factor in rheumatoid arthritis. Clin Chem Lab Med. 2022;60:1617–26.
doi: 10.1515/cclm-2022-0244 pubmed: 35790193
Biliavska I, Stamm TA, Martinez-Avila J, et al. Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort. Ann Rheum Dis. 2013;72:1335–41.
doi: 10.1136/annrheumdis-2012-201909 pubmed: 22984174

Auteurs

Maria Infantino (M)

Laboratorio di Immunologia e Allergologia, Ospedale S. Giovanni di Dio, Via Torregalli, 3, 50143, Firenze, Italy. maria2.infantino@uslcentro.toscana.it.

Boaz Palterer (B)

Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Firenze, Italy.

Maurizio Benucci (M)

Reumatologia, Ospedale S. Giovanni di Dio, Firenze, Italy.

Valentina Grossi (V)

Laboratorio di Immunologia e Allergologia, Ospedale S. Giovanni di Dio, Via Torregalli, 3, 50143, Firenze, Italy.

Silvia Pancani (S)

IRCCS Fondazione Don Carlo Gnocchi, Firenze, Italy.

Mariangela Manfredi (M)

Laboratorio di Immunologia e Allergologia, Ospedale S. Giovanni di Dio, Via Torregalli, 3, 50143, Firenze, Italy.

Nicola Bizzaro (N)

Laboratorio di Patologia Clinica, Ospedale San Antonio, Azienda Sanitaria Universitaria Integrata, Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH